UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 149

Sortiert nach

Title_English

MMW Fortschritte der Medizin, 2022-06, Vol.164 (S2), p.9-9

Bogner, Johannes R.

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial

PloS one, 2018-10, Vol.13 (10), p.e0205368-e0205368

2018

Link zum Volltext

Verfügbarkeit prüfen

SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation

Journal of innate immunity, 2020-09, Vol.12 (5), p.399-409

2020

Link zum Volltext

Verfügbarkeit prüfen

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany

PloS one, 2014-08, Vol.9 (8), p.e104474-e104474

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T Cells

Frontiers in immunology, 2018-04, Vol.9, p.811-811

2018

Link zum Volltext

Verfügbarkeit prüfen

Adaptation of CD8 T cell responses to changing HIV-1 sequences in a cohort of HIV-1 infected individuals not selected for a certain HLA allele

PloS one, 2013-12, Vol.8 (12), p.e80045-e80045

2013

Link zum Volltext

Verfügbarkeit prüfen

Human immunodeficiency virus infection in the elderly

Zeitschrift für Gerontologie und Geriatrie, 2020-03, Vol.53 (2), p.179

Bogner, Johannes R

2020

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

AIDS (London), 2011-06, Vol.25 (10), p.1305-1315

2011

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers and Electrocardiographic Evidence of Myocardial Ischemia in Patients With Human Immunodeficiency Virus Infection

The American journal of cardiology, 2013-03, Vol.111 (5), p.760-764

2013

Link zum Volltext

Verfügbarkeit prüfen

High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection

Translational medicine communications, 2020-01, Vol.5 (1), p.1-11, Article 1

2020

Link zum Volltext

Verfügbarkeit prüfen

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

AIDS (London), 2012-07, Vol.26 (12), p.F31-F37

2012

Link zum Volltext

Verfügbarkeit prüfen

Protease Inhibitor–Based Antiretroviral Prophylaxis during Pregnancy and the Development of Drug Resistance

Clinical infectious diseases, 2010-03, Vol.50 (6), p.890-894

2010

Link zum Volltext

Verfügbarkeit prüfen

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study

Haematologica (Roma), 2018-05, Vol.103 (5), p.857

2018

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of human myeloid-derived suppressor cells after blood draw

Journal of translational medicine, 2016-01, Vol.14 (3), p.2-2, Article 2

2016

Link zum Volltext

Verfügbarkeit prüfen

Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study

AIDS (London), 2013-03, Vol.27 (5), p.842-845

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment

Clinical infectious diseases, 2020-05, Vol.70 (10), p.2131-2140

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

Journal of antimicrobial chemotherapy, 2008-04, Vol.61 (4), p.914-918

2008

Link zum Volltext

Verfügbarkeit prüfen

Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals

Journal of virology, 2014-07, Vol.88 (13), p.7678-7682

2014

Link zum Volltext

Verfügbarkeit prüfen

C-reaktives Protein (CRP)

MMW Fortschritte der Medizin, 2021-03, Vol.163 (5), p.52-53

Bogner, Johannes R

2021

Link zum Volltext

Verfügbarkeit prüfen

Nevirapine extended-release for the treatment of HIV-1 infection

Expert review of anti-infective therapy, 2012-01, Vol.10 (1), p.21-30

Bogner, Johannes R

2012

Link zum Volltext

Verfügbarkeit prüfen

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT

AIDS research and therapy, 2008-10, Vol.5 (1), p.22-22, Article 22

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 149

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals

KollektionWiley Online Library

ThemaFamily Medicine

ThemaInternal Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Englisch
(109)
Deutsch
(40)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Title_English

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial

SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany

Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T Cells

Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

Adaptation of CD8 T cell responses to changing HIV-1 sequences in a cohort of HIV-1 infected individuals not selected for a certain HLA allele

Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial

Human immunodeficiency virus infection in the elderly

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

Biomarkers and Electrocardiographic Evidence of Myocardial Ischemia in Patients With Human Immunodeficiency Virus Infection

High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies

Protease Inhibitor–Based Antiretroviral Prophylaxis during Pregnancy and the Development of Drug Resistance

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study

Kinetics of human myeloid-derived suppressor cells after blood draw

Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals

C-reaktives Protein (CRP)

Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial

Nevirapine extended-release for the treatment of HIV-1 infection

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT

Aktive Filter

Suchergebnisse filtern